DisclosureWe earn commission on partner links; ranking is set by clinician-vetted methodology — not advertisers.
Tru Niagen delivers patented nicotinamide riboside (Niagen) to support cellular NAD+ levels, marketed as a daily foundational supplement for healthy aging.
Tru Niagen does what it claims at the biochemical level: in a randomized, placebo-controlled trial, 300mg daily raised whole-blood NAD+ by roughly 51% within two weeks, and the ingredient has one of the deepest safety dossiers of any longevity supplement. The catch is that raising NAD+ has not translated into proven anti-aging outcomes (energy, strength, metabolism, or lifespan) in controlled human trials. It is a low-risk bet for biohackers comfortable paying for a biomarker change without guaranteed felt benefits.
Tru Niagen delivers Niagen, a patented form of nicotinamide riboside (NR), a relative of vitamin B3. Your cells convert NR into NAD+ (nicotinamide adenine dinucleotide), a coenzyme essential for turning food into cellular energy, supporting DNA repair, and fueling the activity of enzymes called sirtuins. NAD+ levels tend to decline with age, and the theory is that replenishing NAD+ may support healthier cellular aging. Importantly, the supplement reliably raises blood NAD+; whether that higher NAD+ produces meaningful health benefits in people is still an open question.
The strongest, most consistent finding is at the biomarker level: in a randomized, double-blind, placebo-controlled trial of 140 overweight but otherwise healthy adults (Conze et al., 2019), Niagen raised whole-blood NAD+ dose-dependently within two weeks (about 22% at 100mg, 51% at 300mg, and 142% at 1000mg per day), and the increase was sustained over the 8-week study. Downstream clinical benefits are far less convincing. Dollerup et al. found that NR (1000mg twice daily, 2000mg/day for 12 weeks) raised NAD+ but did not meaningfully improve insulin sensitivity, skeletal-muscle mitochondrial function, or body composition in obese, insulin-resistant men. A 2018 crossover trial in middle-aged and older adults (Martens et al., 1000mg/day) raised NAD+ by roughly 60% but found that reductions in blood pressure and aortic stiffness did not reach statistical significance. So NR clearly elevates NAD+; the evidence that it slows aging or improves performance in healthy people remains weak.
Across trials at doses up to 1000-2000mg/day, Niagen has been well tolerated, with adverse-event rates similar to placebo and, notably, no skin flushing (a common complaint with older high-dose niacin). In real-world use, mild and transient effects can include nausea, stomach discomfort, bloating, headache, or fatigue. No serious adverse events have been clearly attributed to NR in published trials. Long-term safety beyond a few months is less studied, and because NAD+ influences cell metabolism, people with cancer or other proliferative conditions should be cautious and consult a physician before use.
Starts at $40/mo from Tru Niagen.
As of 2026, Tru Niagen 300mg costs $49 for a 30-count bottle (about one month) at full price directly from the manufacturer, or $39.20/month on subscription (20% off, with free shipping). Larger bottles lower the per-capsule cost: a 90-count is $127 ($101.60 on subscription) and a 180-count is $244 ($195.20 on subscription), which works out to roughly $1.08-$1.41 per day depending on size and whether you subscribe. At higher daily doses, monthly cost rises proportionally. As a dietary supplement it is not covered by insurance and rarely qualifies for HSA/FSA reimbursement without a doctor's letter. Third-party retailers (Amazon, Costco, Walmart) sometimes price below MSRP.
If your goal is a clinically documented, well-tolerated way to elevate NAD+, Tru Niagen is among the most credible options on the market, backed by dozens of clinical studies and FDA GRAS no-objection status. If your goal is to feel younger, sleep better, or measurably improve metabolism, the human evidence does not yet support those promises, and much of the supporting research is tied to the ingredient maker. Buy it for the documented biochemistry and the safety record, not for guaranteed results.
It works at the biochemical level: in a randomized, placebo-controlled trial, 300mg daily raised whole-blood NAD+ by about 51% within two weeks. But human studies have not proven that this NAD+ boost produces felt benefits like more energy, better metabolism, or slower aging, so 'works' depends on whether you mean the biomarker or the outcome.
No supplement is FDA-approved. Tru Niagen's Niagen ingredient has received FDA GRAS (Generally Recognized as Safe) no-objection status (GRN 635) and two New Dietary Ingredient notifications, which address safety, not proof of anti-aging effectiveness. The FDA does not evaluate supplements for efficacy before sale.
It is generally well tolerated, with trial adverse-event rates similar to placebo and no flushing. Mild, occasional effects can include nausea, stomach upset, bloating, headache, or fatigue. No serious side effects have been clearly linked to it in published trials, though long-term (multi-year) safety is not well studied.
The standard and evidence-backed dose is one 300mg capsule daily, the amount shown to raise blood NAD+ by roughly 51% in a randomized trial. The label allows up to three capsules (900mg) daily, and the ingredient has been studied as safe at up to 2,000mg/day for several weeks. Take it at the same time each day for consistency.
As of 2026, a 30-day bottle of Tru Niagen 300mg costs $49 at full price or $39.20/month on subscription (20% off) with free shipping. Larger 90-count ($127) and 180-count ($244) bottles lower the per-day cost. It is not covered by insurance and rarely qualifies for HSA/FSA without a doctor's letter.
It is worth it if you specifically want a safe, well-studied way to raise NAD+ and accept that downstream benefits are unproven. If you expect guaranteed energy, anti-aging, or metabolic improvements, the human evidence does not yet justify the roughly $39-$49 monthly cost. It is best viewed as a low-risk biochemistry bet, not a results guarantee.
It targets a mechanism linked to aging (declining NAD+), but no human trial has shown that it extends lifespan or measurably slows aging. The longevity case is theoretical and based on a biomarker change (higher NAD+), not on demonstrated outcomes. Talk to a clinician before relying on any supplement for healthy aging.
Avoid it if you are pregnant or breastfeeding (it is untested in these groups), and consult a doctor first if you have cancer or a cancer history, kidney or liver disease, or take prescription medications. It is not intended for children. As with any supplement, clear it with your clinician if you have a chronic health condition.
Tru Niagen (NR) and NMN both raise NAD+, and neither has proven outcome benefits in humans; NR has more published human safety data and FDA clearances. NMN's US supplement status was contested after the FDA excluded it in 2022, but the agency reversed course in 2025 and now considers NMN lawful in supplements. Unlike high-dose niacin, NR causes no flushing.